Adv Skin Wound Care. 2020 May;33(5):240-251. doi: 10.1097/01.ASW.0000658572.14692.fb.
To provide information about the effectiveness of topical analgesic and local anesthetic agents for reducing pain associated with chronic leg ulcers.
This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care.
LEARNING OBJECTIVES/OUTCOMES: After participating in this educational activity, the participant will:1. Distinguish adverse reactions to topical analgesics and local anesthetic agents.2. Evaluate the effectiveness of topical analgesics and local anesthetic agents for pain associated with chronic leg ulcers.3. Identify substances used as topical analgesics and local anesthetic agents and the application of those agents.
To examine the evidence related to the effectiveness of topical analgesic and topical local anesthetic agents for reducing pain associated with chronic leg ulcers.A systematic search and review of the literature were undertaken using key search terms such as leg ulcers, topical anesthetics, topical analgesics, and pain. Six databases were electronically searched for articles published between January 1990 and August 2019.A total of 23 articles were identified that met the inclusion criteria. Data were extracted using content analysis. Most of the included studies were randomized controlled trials; however, the reported methodology for most of studies was poor, so the validity and reliability of the evidence are uncertain. Lidocaine/prilocaine cream, ibuprofen foam, and morphine gel were the most examined topical agents. Lidocaine/prilocaine cream significantly improved wound-related pain compared with all other studied agents. For topical analgesic agents, ibuprofen foam reduced chronic leg ulcer pain significantly, whereas morphine gel was ineffective.Lidocaine/prilocaine cream and ibuprofen foam are effective agents for reducing wound-related pain associated with chronic leg ulcers. Effective use of topical agents could reduce the need for systemic pain relief agents, mitigating potential adverse effects, while giving clinicians another treatment option to manage wound-related pain associated with chronic leg ulcers.
提供有关局部镇痛和局部麻醉剂减轻慢性腿部溃疡相关疼痛的有效性信息。
本继续教育活动面向对皮肤和伤口护理感兴趣的医师、医师助理、执业护士和注册护士。
学习目标/成果:参加本教育活动后,参与者将:1. 区分局部镇痛剂和局部麻醉剂的不良反应。2. 评估局部镇痛剂和局部麻醉剂治疗慢性腿部溃疡相关疼痛的有效性。3. 识别用作局部镇痛剂和局部麻醉剂的物质以及这些制剂的应用。
研究局部镇痛剂和局部麻醉剂减轻慢性腿部溃疡相关疼痛的有效性证据。使用关键搜索词(如腿部溃疡、局部麻醉剂、局部镇痛药和疼痛)进行了系统的文献搜索和审查。电子搜索了六个数据库,以查找 1990 年 1 月至 2019 年 8 月期间发表的文章。共确定了 23 篇符合纳入标准的文章。使用内容分析提取数据。大多数纳入的研究都是随机对照试验;然而,大多数研究报告的方法学较差,因此证据的有效性和可靠性不确定。利多卡因/丙胺卡因乳膏、布洛芬泡沫剂和吗啡凝胶是研究最多的局部制剂。利多卡因/丙胺卡因乳膏与所有其他研究药物相比,显著改善了与伤口相关的疼痛。对于局部镇痛剂,布洛芬泡沫剂显著减轻慢性腿部溃疡疼痛,而吗啡凝胶无效。利多卡因/丙胺卡因乳膏和布洛芬泡沫剂是减轻慢性腿部溃疡相关伤口疼痛的有效药物。局部制剂的有效使用可以减少对全身止痛药物的需求,减轻潜在的不良反应,同时为临床医生提供另一种治疗选择,以管理与慢性腿部溃疡相关的伤口疼痛。